Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Biocon Ltd

    Jump to

    • Biocon did not buy electoral bonds for political donations, I did: Founder Kiran Mazumdar-Shaw

      Kiran Mazumdar-Shaw said, 'I want to make it clear that what I do personally has no connection with my company... It was my personal money and my account.' Her total donation through electoral bonds amounted to Rs 6 crore.

    • Biocon swings back to profit in Q3, revenue up 34.4%

      Biocon Q3 results: The company reported a net loss of Rs 42 crore in the same period of the previous year

    • Biocon acquires Eywa Pharma's New Jersey facility for $7.7 million

      The biotechnology giant stated in an exchange filing that the facility in New Jersey's Cranbury in the US has the potential for further expanding its capacity up to two billion tablets or capsules per year

    • Gainers & Losers: 10 stocks that moved the most on July 24

      About 1,730 shares advanced, 1,874 declined and 147 remained unchanged on July 24.

    • John Shaw, husband of Kiran Mazumdar-Shaw, passes away

    • Ireland regulator reports manufacturing deficiency at Biocon's Bengaluru plant

    • Biocon Q4 profit declines by 4% to Rs 283 crore

    • Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow

    • Biocon consolidated net profit dips 18% to Rs 138 crore in Q2

    • Kiran Mazumdar-Shaw becomes first Indian woman to join Board of Trustees of Memorial Sloan Kettering Cancer Center

    • Biocon to acquire 26% stake in Hinduja Renewables Two

    • Biocon's partner Equillium gets USFDA nod to begin phase-3 trial of itolizumab on COVID-19 patients

    • Lockdown has to end: Kiran Mazumdar-Shaw

    • Biocon and Mylan launch Fulphila, a biosimilar to Pegfilgrastim in Australia

    • Market Headstart: Nifty likely to open lower; 3 stocks which could give 3-5% return

    • Markets@Moneycontrol: Nifty likely to open higher; 3 stocks which could give 4-9%

    • Markets@Moneycontrol: Nifty likely to open flat; 3 stocks which could give 5-11% return

    • Biocon Q1 Net jumps 23% to Rs 126 crore

    • Biocon Q2 net drops as energy costs, wages rise

      Biocon Ltd, India top biotechnology company, reported a 4% drop in quarterly profit due to higher energy costs and rise in wages, but said strong demand from branded formulations offered opportunities for growth.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347